Sun pharma industries News: Sun pharma industries Latest News, Sun pharma industries Today news, Sun pharma industries Breaking News

Sun Pharma Q4FY26 brokerage outlook and target price analysis

Sun Pharma Q4FY26: Why 3 Brokerages recommend a ‘Buy’ but one is stepping back

Sun Pharma’s Q4FY26 numbers missed on margins but not on confidence. Three brokerages stayed bullish as specialty medicines, India growth…

May 25, 2026 11:30 IST

Pharma dividend watch: Abbott India, Torrent Pharma, Sun Pharma among 7 stocks with upcoming record dates

Pharma stocks including Abbott India, Sun Pharma, Torrent Pharma, Cipla and Divi’s Laboratories are in focus after announcing FY26 dividends…

Updated: May 25, 2026 07:55 IST

Vedanta share price, Vedanta demerger news, Anil Agarwal Vedanta, Vedanta stock outlook 2026, Vedanta demerger 5 companies

Vedanta’s big split: Emkay sees 16% upside as demerger unlocks hidden value

Vedanta’s demerger unlocks hidden value, with Emkay projecting a 16% upside—discover if the split benefits your portfolio today!

May 4, 2026 11:41 IST

Nifty IT index today, IT stocks rally, Infosys share price, Tech Mahindra stock

Emmvee Photovoltaic to KFin Tech: Jefferies 3 ‘Buy’ stocks with an upside between 26-36%

Jefferies bullish on Emmvee Photovoltaic, Bajaj Finance, KFin Tech; sees 26–36% upside on strong earnings growth

Updated: April 30, 2026 13:31 IST

ICICI Bank, HDFC Bank, AU Small Finance Bank, Motilal Oswal top banking picks

Federal Bank to Indian Bank: Motilal Oswal’s financial picks with up to 34% upside

Motilal Oswal bullish on Federal Bank, Indian Bank, IIFL Finance, Five Star; sees up to 34% upside amid sector pressure

April 30, 2026 12:44 IST

Nifty April expiry short covering rally rollover data India

April Rollover Alert: Why Sun Pharma, ONGC stand out but 1 sector is facing fresh ‘Short’ trap – Ambit reveals

Markets surged, but not on fresh buying: Ambit sees a short-covering rally as rollover data reveals selective bets in pharma,…

April 30, 2026 12:08 IST

Rupee nears 95 Vs US dollar: 3 macro headwinds and a surprise pharma outflow among key concerns

Rupee nears 95 per US dollar amid oil price surge, pharma outflow, and weak IIP; know the outlook for currency.

April 29, 2026 12:13 IST

Sensex, Nifty snap 3-day losing streak with buying in beaten-down heavyweight stocks

India and New Zealand have signed a Free Trade Agreement set to be operational by year-end, offering duty-free access for…

April 27, 2026 21:32 IST

Paytm: Why Goldman Sachs sees 22% upside potential after RBI cancels PPBL license

Goldman Sachs sees 22% upside for Paytm stock despite PPBL setback; explore why experts remain bullish!

April 27, 2026 13:29 IST

Coforge and Vodafone Idea share price rally midday India

Stocks making the biggest moves midday: Sun Pharma, Axis Bank, Paytm, Cohance and more

Sun Pharma’s mega deal sparks a rally, but Paytm’s RBI shock and Axis Bank’s earnings drag sentiment. Here’s what’s really…

Updated: April 27, 2026 13:38 IST

Rupee falls for fifth straight session as oil trades over $100 – Iran conflict weighs on currency

Rupee drops for a fifth day as oil tops $100 and US-Iran tensions rise—see what’s next for the currency.

Updated: April 27, 2026 11:59 IST

Sun Pharma-Organon $11.75 billion deal – 5 ‘must know’ details – Stock surges 7%

From nearly doubling EBITDA to becoming a top player in biosimilars and women’s health, here are five key takeaways investors…

April 27, 2026 11:11 IST

Sun Pharma’s $11.75 billion Organon deal.

Sun Pharma in global reckoning with daring Organon deal; all eyes now on debt & EBITDA

A quick back-of-the-envelope calculations by analysts and pharma gurus show ~$8.6B debt at $1.9B EBITDA is 4.5x leverage — it…

Updated: April 27, 2026 09:55 IST

Sun Pharma surges 7% – To acquire Organon in $11.75 billion all-cash deal; expects cash flow to nearly double

Sun Pharmaceutical to acquire Organon in an $11.75 billion all-cash deal, marking its entry into biosimilars and strengthening its global…

Updated: April 27, 2026 10:18 IST

Indian stock market, Motilal Oswal report, India vs emerging markets

Markets end on a stable note but Nifty closes below 24,100, Sensex up 600 points; Sun Pharma the big star in trading today

Sensex climbs 639 points, Nifty ends below 24,100 led by Sun Pharma; explore today’s top market movers and global cues!

Updated: April 27, 2026 15:38 IST

Sharp slide: Markets clock worst 3-day slump since mid-march, Sensex, Nifty end week with 2% losses; Tech cracks

Sensex and Nifty closed over 1% lower amid IT stock declines and global market caution; explore key movers and sector…

Updated: April 24, 2026 15:46 IST

Tech Mahindra Q4 result: Profit up 20% sequentially, revenue growth aided by favourable currency exchange

Tech Mahindra reports 20.5% sequential rise in Q4 profit with revenue beating estimates, while margins improve and strong deal wins…

Updated: April 22, 2026 18:47 IST

Today Sensex, Nifty 50, Stock Market Live Updates:

Markets end in the red: Nifty closes below 23,200; Sensex down 100 points, HDFC Bank, Titan see sharp cut

Sensex and Nifty closed slightly lower amid broad sectoral weakness—see which stocks moved and track market trends now.

Updated: April 16, 2026 15:34 IST

Sun Pharmaceutical Industries

Related News

Trending Topics